- Home
- OIS vs ALDX Comparison
OIS vs ALDX Comparison
Compare OIS & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OIS | ALDX |
|---|---|---|
| Founded | 1995 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 682.7M | 317.7M |
| IPO Year | 2000 | 2014 |
Fundamental Metrics
Financial Performance| Metric | OIS | ALDX |
|---|---|---|
| Price | $11.23 | $1.51 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $14.00 | $5.50 |
| AVG Volume (30 Days) | 905.9K | ★ 6.0M |
| Earning Date | 04-30-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 40.43 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,088,133,000.00 | N/A |
| Revenue This Year | $3.73 | N/A |
| Revenue Next Year | $5.36 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 62.26 | N/A |
| 52 Week Low | $3.08 | $1.07 |
| 52 Week High | $14.50 | $6.18 |
Technical Indicators
Market Signals| Indicator | OIS | ALDX |
|---|---|---|
| Relative Strength Index (RSI) | 45.16 | 27.11 |
| Support Level | $5.72 | $1.07 |
| Resistance Level | $12.79 | $5.75 |
| Average True Range (ATR) | 0.52 | 0.24 |
| MACD | -0.19 | 0.01 |
| Stochastic Oscillator | 10.33 | 31.20 |
Price Performance
Historical ComparisonAbout OIS Oil States International Inc.
Oil States International Inc is a provider of manufactured products and services to customers in the energy, military and industrial sectors. The company operates through three business segments - Offshore Manufactured Products, Completion and Production Services and Downhole Technologies. Its customers include many national oil and natural gas companies, and independent oil and natural gas companies, offshore drilling companies and other oilfield service, defense and industrial companies.
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.